Antibody-drug conjugate including novel cyclic dinucleotide derivative
MYPI2026002831A0Undetermined Publication Date: 2021-09-06DAIICHI SANKYO CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026002831
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-03-05
- Filing Date
- 2021-03-05
- Publication Date
- 2021-09-06
Abstract
[Problem] It is desired to develop an antibody-drug conjugate capable of being systemically administered and delivering a STING agonist specifically to a target cells or organ (for example, a tumor lesion), and a therapeutic agent and / or therapeutic method using the antibody-drug conjugate for diseases related to STING agonist activity, for example, diseases (for example, cancers) to which immunostimulation therapy can be applied. [Solution] The present invention provides a novel antibody-CDN derivative conjugate which can be systemically administered and exhibits an antitumor effect against an antigen-expressing tumor.
Need to check novelty before this filing date? Find Prior Art
